vs
OLAPLEX HOLDINGS, INC.（OLPX）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是OLAPLEX HOLDINGS, INC.的2.0倍（$207.3M vs $105.1M），OLAPLEX HOLDINGS, INC.净利率更高（-12.5% vs -62.0%，领先49.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 4.3%），OLAPLEX HOLDINGS, INC.自由现金流更多（$32.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 3.1%）
Olaplex Holdings是一家专业美容企业，主打专利头发键结构修复护发产品，运营沙龙专业分销、直面消费者销售、第三方零售三大核心板块，产品可修复烫染、高温等导致的发质损伤，销售网络覆盖北美、欧洲及亚太地区。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
OLPX vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.1M | $207.3M |
| 净利润 | $-13.1M | $-128.6M |
| 毛利率 | 68.0% | — |
| 营业利润率 | -4.3% | -54.7% |
| 净利率 | -12.5% | -62.0% |
| 营收同比 | 4.3% | 25.9% |
| 净利润同比 | -48.9% | 3.5% |
| 每股收益（稀释后） | $-0.02 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $105.1M | $207.3M | ||
| Q3 25 | $114.6M | $159.9M | ||
| Q2 25 | $106.3M | $166.5M | ||
| Q1 25 | $97.0M | $139.3M | ||
| Q4 24 | $100.7M | $164.6M | ||
| Q3 24 | $119.1M | $139.5M | ||
| Q2 24 | $103.9M | $147.0M | ||
| Q1 24 | $98.9M | $108.8M |
| Q4 25 | $-13.1M | $-128.6M | ||
| Q3 25 | $11.1M | $-180.4M | ||
| Q2 25 | $-7.7M | $-115.0M | ||
| Q1 25 | $465.0K | $-151.1M | ||
| Q4 24 | $-8.8M | $-133.2M | ||
| Q3 24 | $14.8M | $-133.5M | ||
| Q2 24 | $5.8M | $-131.6M | ||
| Q1 24 | $7.7M | $-170.7M |
| Q4 25 | 68.0% | — | ||
| Q3 25 | 69.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 66.3% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | 69.7% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | -4.3% | -54.7% | ||
| Q3 25 | 3.7% | -106.9% | ||
| Q2 25 | -1.1% | -64.8% | ||
| Q1 25 | 8.7% | -102.6% | ||
| Q4 24 | 3.0% | -74.3% | ||
| Q3 24 | 23.5% | -94.6% | ||
| Q2 24 | 15.7% | -79.1% | ||
| Q1 24 | 19.8% | -151.9% |
| Q4 25 | -12.5% | -62.0% | ||
| Q3 25 | 9.7% | -112.8% | ||
| Q2 25 | -7.3% | -69.0% | ||
| Q1 25 | 0.5% | -108.5% | ||
| Q4 24 | -8.7% | -80.9% | ||
| Q3 24 | 12.4% | -95.7% | ||
| Q2 24 | 5.6% | -89.5% | ||
| Q1 24 | 7.8% | -156.8% |
| Q4 25 | $-0.02 | $-1.28 | ||
| Q3 25 | $0.02 | $-1.81 | ||
| Q2 25 | $-0.01 | $-1.17 | ||
| Q1 25 | $0.00 | $-1.57 | ||
| Q4 24 | $-0.01 | $-1.34 | ||
| Q3 24 | $0.02 | $-1.40 | ||
| Q2 24 | $0.01 | $-1.52 | ||
| Q1 24 | $0.01 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $318.7M | $421.0M |
| 总债务越低越好 | $352.3M | — |
| 股东权益账面价值 | $879.4M | $-80.0M |
| 总资产 | $1.5B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.40× | — |
8季度趋势，按日历期对齐
| Q4 25 | $318.7M | $421.0M | ||
| Q3 25 | $286.4M | $202.5M | ||
| Q2 25 | $289.3M | $176.3M | ||
| Q1 25 | $580.9M | $127.1M | ||
| Q4 24 | $586.0M | $174.0M | ||
| Q3 24 | $538.8M | $150.6M | ||
| Q2 24 | $507.9M | $480.7M | ||
| Q1 24 | $507.5M | $112.3M |
| Q4 25 | $352.3M | — | ||
| Q3 25 | $352.1M | — | ||
| Q2 25 | $351.9M | — | ||
| Q1 25 | $649.1M | — | ||
| Q4 24 | $650.5M | — | ||
| Q3 24 | $651.8M | — | ||
| Q2 24 | $653.1M | — | ||
| Q1 24 | $654.4M | — |
| Q4 25 | $879.4M | $-80.0M | ||
| Q3 25 | $888.7M | $9.2M | ||
| Q2 25 | $874.2M | $151.3M | ||
| Q1 25 | $878.3M | $144.2M | ||
| Q4 24 | $874.4M | $255.0M | ||
| Q3 24 | $879.7M | $346.8M | ||
| Q2 24 | $863.3M | $432.4M | ||
| Q1 24 | $855.7M | $140.3M |
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | $1.8B | $1.5B | ||
| Q3 24 | $1.8B | $1.5B | ||
| Q2 24 | $1.8B | $1.6B | ||
| Q1 24 | $1.8B | $1.3B |
| Q4 25 | 0.40× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.76× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.7M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 31.0% | -48.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $58.3M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $32.7M | $-99.8M | ||
| Q3 25 | $8.0M | $-91.4M | ||
| Q2 25 | $20.9M | $-108.3M | ||
| Q1 25 | $-2.9M | $-166.5M | ||
| Q4 24 | $49.7M | $-79.3M | ||
| Q3 24 | $33.5M | $-67.0M | ||
| Q2 24 | $16.2M | $-77.0M | ||
| Q1 24 | $43.7M | $-190.7M |
| Q4 25 | $32.6M | $-100.8M | ||
| Q3 25 | $7.9M | $-92.7M | ||
| Q2 25 | $20.8M | $-110.7M | ||
| Q1 25 | $-3.0M | $-167.8M | ||
| Q4 24 | $49.2M | $-79.5M | ||
| Q3 24 | $33.3M | $-68.6M | ||
| Q2 24 | $16.1M | $-79.0M | ||
| Q1 24 | $43.3M | $-193.9M |
| Q4 25 | 31.0% | -48.6% | ||
| Q3 25 | 6.9% | -58.0% | ||
| Q2 25 | 19.6% | -66.5% | ||
| Q1 25 | -3.1% | -120.5% | ||
| Q4 24 | 48.9% | -48.3% | ||
| Q3 24 | 28.0% | -49.2% | ||
| Q2 24 | 15.5% | -53.7% | ||
| Q1 24 | 43.7% | -178.2% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.1% | 1.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.5% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -6.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.26× | — | ||
| Q2 24 | 2.81× | — | ||
| Q1 24 | 5.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
